Elan rated at sell by Citigroup

Citigroup Investment Research analyst Andrew Swanson rated Elan Corp. plc at sell on a reported fourth-quarter 2005 loss of $0.14 per share. Citigroup had forecast an $0.11 loss and the consensus expectation was of a $0.19 loss. Revenues of $140.4 million were slightly ahead of the analyst's expected $137.6 million. Shares of the Dublin, Ireland, biopharmaceutical company were up $1.26, or 8.60%, at $15.91 on volume of 21,750,900 shares versus the three-month running average of 9,445,580 shares. (NYSE: ELN)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.